AbCellera Biologics Inc. ABCL Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $102.06M-44.6% | $128.51M-17.8% | $108.16M-28.7% | $117.44M-32.2% | $184.27M+24.0% | ||
| $25M0.0% | $25M0.0% | $25M0.0% | $25M0.0% | $25M0.0% | ||
| $39.16M— | $39.41M— | $71.25M— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $98.1M+3.6% | $111.11M+65.5% | $133.01M+207% | $116.76M+191% | $94.71M+67.6% | ||
| $39.8M+73.0% | $55.7M+110% | $46.66M+46.4% | $36.05M+14.2% | $23M-33.1% | ||
| $664.6M-13.1% | $728.23M-3.1% | $695.14M-6.4% | $742.15M-3.8% | $764.98M-6.0% | ||
| $47.81M0.0% | $47.81M0.0% | $47.81M0.0% | $47.81M0.0% | $47.81M0.0% | ||
| $17.21M-7.6% | $38.38M-8.9% | $17.91M-16.6% | $18.26M-15.0% | $18.61M-13.4% | ||
| $69.14M+12.3% | $51.95M-46.2% | $53.07M-60.5% | $57.45M-48.9% | $61.56M-41.3% | ||
| $32.5M+0.6% | $32.5M-60.5% | $29.1M-9.9% | $33.1M+2.5% | $32.3M0.0% | ||
| $31.86M-36.2% | $30.94M-36.9% | $51.81M+34.4% | $50.87M+35.7% | $49.94M+37.2% | ||
| $642.52M+10.9% | $628.72M+3.2% | $660.85M+1.7% | $659.92M+3.0% | $579.23M-10.8% | ||
| $1.31B-2.8% | $1.36B-0.3% | $1.36B-2.6% | $1.4B-0.7% | $1.34B-8.1% | ||
| $20.81M-36.6% | $25.23M-26.6% | $31.77M-8.7% | $32.04M+20.5% | $32.8M+21.9% | ||
| $3.93M+23.2% | $10.76M+28.4% | $7.23M+20.7% | $4.97M+14.0% | $3.19M+11.9% | ||
| $7.74M-58.8% | $13.53M0.0% | $15.69M+181% | $16.95M+165% | $18.79M+77.8% | ||
| $5.87M+26.6% | $5.82M+25.8% | $5.17M+0.8% | $4.9M-12.6% | $4.64M-16.2% | ||
| $8.99M-72.4% | $17.03M-11.4% | $5.85M-27.8% | $11.63M+46.0% | $32.54M+280% | ||
| $47.29M-37.3% | $64.31M-16.1% | $68.8M-13.5% | $67.02M-4.8% | $75.4M-28.1% | ||
| $134.31M+112% | $137.4M+126% | $137.05M+107% | $137.18M+106% | $63.21M-7.2% | ||
| —— | —— | —— | —— | —— | ||
| $11.32M+597% | $13.88M+93.7% | $1.39M-9.1% | $1.56M-75.4% | $1.62M-71.7% | ||
| $321.74M+30.9% | $325.74M+43.0% | $323.15M+37.4% | $327.96M+41.9% | $245.83M+7.7% | ||
| $369.03M+14.9% | $390.05M+28.1% | $391.95M+24.5% | $394.99M+31.0% | $321.23M-3.6% | ||
| $816.53M+3.3% | $802.34M+3.2% | $794.47M+2.8% | $791.67M+2.8% | $790.07M+3.3% | ||
| $196.62M+16.6% | $198.28M+19.2% | $192.8M+24.1% | $181.48M+28.9% | $168.6M+31.7% | ||
| -$72.65M-202% | -$29.48M-125% | -$20.54M-114% | $36.58M-81.9% | $71.31M-70.2% | ||
| -$2.42M+65.4% | -$4.23M+3.3% | -$2.7M-119% | -$2.66M-28.2% | -$7M-285% | ||
| $938.08M-8.3% | $966.9M-8.4% | $964.04M-10.6% | $1.01B-9.4% | $1.02B-9.5% | ||
| $1.31B-2.8% | $1.36B-0.3% | $1.36B-2.6% | $1.4B-0.7% | $1.34B-8.1% | ||
| $103.8M-44.4% | $155.25M-15.4% | $110.45M-28.2% | $119.73M-31.8% | $186.56M+23.7% | ||
| $427.67M-4.1% | $405.31M-13.6% | $412.51M-20.1% | $460.64M-11.8% | $446M-22.4% | ||
| $36.76M-8.1% | $58.29M+73.4% | $41.46M+32.1% | $47.31M+30.9% | $40.01M+16.2% | ||
| $504.73M-16.6% | $533.83M-14.7% | $495.67M-22.9% | $553.08M— | $605.27M— | ||
| $98.1M+3.6% | $111.11M+65.5% | $133.01M+207% | $116.76M+191% | $94.71M+67.6% | ||
| $32.5M+0.6% | $32.5M+0.6% | $29.1M-9.9% | $33.1M+2.5% | $32.3M0.0% | ||
| $69.14M+12.3% | $51.95M-46.2% | $53.07M-60.5% | $57.45M-48.9% | $61.56M-41.3% | ||
| $32.5M+0.6% | $32.5M+0.6% | $29.1M-9.9% | $33.1M+2.5% | $32.3M0.0% | ||
| —— | —— | —— | —— | —— | ||
| $69.32M-23.9% | $69.32M-23.9% | $91.13M0.0% | $91.13M-26.0% | $91.13M-41.3% | ||
| $30.2M-43.5% | $33.59M— | $51.48M— | $56.24M— | $53.48M— | ||
| $32.5M+0.6% | $32.5M+0.6% | $29.1M-9.9% | $33.1M+2.5% | $32.3M0.0% | ||
| $134.3M+95.4% | $136.12M+104% | $137.91M+102% | $136.94M— | $68.74M— | ||
| —— | —— | —— | —— | —— | ||
| $37.46M-9.1% | $38.38M-8.9% | $39.32M-25.2% | $40.26M-53.0% | $41.19M-65.3% | ||
| $65.31M-19.9% | $62.58M-24.0% | $93.3M+11.0% | $90.37M+18.8% | $81.57M+13.9% | ||
| $134.3M+95.4% | $136.12M+104% | $137.91M+102% | $136.94M— | $68.74M— | ||
| $69.14M+12.3% | $51.95M-46.2% | $53.07M-60.5% | $57.45M-48.9% | $61.56M-41.3% | ||
| $422.81M+21.8% | $428M+25.7% | $427.36M+29.0% | $424.02M— | $347.1M— | ||
| $134.3M+95.4% | $136.12M+104% | $137.91M+102% | $136.94M— | $68.74M— | ||
| $69.14M+12.3% | $51.95M-46.2% | $53.07M-60.5% | $57.45M-48.9% | $61.56M-41.3% | ||
| $39.55M-17.3% | $50.78M-7.7% | $53.12M-1.2% | $50.07M+13.9% | $47.84M+11.5% | ||
| $3.93M+23.2% | $10.76M+28.4% | $7.23M+20.7% | $4.97M+14.0% | $3.19M+11.9% | ||
| $20.81M-36.6% | $25.23M-26.6% | $31.77M-8.7% | $32.04M+20.5% | $32.8M+21.9% | ||
| $3.93M+23.2% | $10.76M+28.4% | $7.23M+20.7% | $4.97M+14.0% | $3.19M+11.9% | ||
| $176.11M+12.0% | $174.45M— | $169.12M— | $167.53M— | $157.19M— | ||
| $140.18M+107% | $143.22M+119% | $142.22M+99.2% | $142.08M+97.2% | $67.85M-7.8% | ||
| 303.9M+2.8% | 300.6M+1.6% | 299M+2.8% | 295.8M+1.7% | 295.8M+1.7% | ||
| $196.62M+16.6% | $198.28M+19.2% | $192.8M+24.1% | $181.48M+28.9% | $168.6M+31.7% | ||
| $816.53M+3.3% | $802.34M+3.2% | $794.47M+2.8% | $791.67M+2.8% | $790.07M+3.3% | ||
| $427.67M-4.1% | $405.31M-13.6% | $412.51M-20.1% | $460.64M-11.8% | $446M-22.4% | ||
| $103.8M-44.4% | $155.25M-15.4% | $110.45M-28.2% | $119.73M-31.8% | $186.56M+23.7% | ||
| $0.00— | $0.00— | $0.00— | $0.00— | $0.00— | ||
| $303.95M+2.8% | $300.6M+1.6% | $299.01M+2.8% | $295.76M+1.7% | $295.76M+1.7% | ||
| $303.95M+2.8% | $300.6M+1.6% | $299.01M+2.8% | $295.76M+1.7% | $295.76M+1.7% | ||
| $8.99M-72.4% | $17.03M-11.4% | $21.54M+57.5% | $28.58M+98.9% | $32.54M+70.0% | ||
| $8.95M+24.1% | $8.98M+17.3% | $8.94M+13.8% | $8.17M+10.3% | $7.21M-5.1% | ||
| $32.5M+0.6% | $32.5M+0.6% | $29.1M-9.9% | $33.1M+2.5% | $32.3M0.0% | ||
| $31.86M-36.2% | $30.94M-36.9% | $51.81M+34.4% | $50.87M+35.7% | $49.94M+37.2% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $69.32M-23.9% | $69.32M-23.9% | $91.13M0.0% | $91.13M-26.0% | $91.13M-41.3% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $185.05M+12.6% | $183.44M— | $178.06M— | $175.7M— | $164.41M— | ||
| —— | —— | —— | —— | —— | ||
| $39.8M+73.0% | $55.7M+110% | $46.66M+46.4% | $36.05M+14.2% | $23M-33.1% | ||
| —— | —— | —— | —— | —— | ||
| $11.28M+39.3% | $9.67M+12.1% | $15.11M+31.3% | $10.7M+26.0% | $8.1M-62.2% | ||
| $63.53M+44.5% | $57.61M+45.1% | $52.63M+35.9% | $48.51M— | $43.98M— | ||
| $486.34M+24.4% | $485.62M+27.7% | $479.99M+29.7% | $472.53M— | $391.08M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are AbCellera Biologics Inc.'s total assets?
- AbCellera Biologics Inc. (ABCL) holds $1.3B in total assets, down 2.8% year over year.
- How much debt does AbCellera Biologics Inc. have?
- AbCellera Biologics Inc. carries $140.2M in total debt against $938.1M of shareholders' equity, a debt-to-equity ratio of 0.15.
- How much cash does AbCellera Biologics Inc. have?
- AbCellera Biologics Inc. holds $102.1M in cash and equivalents.
- Can AbCellera Biologics Inc. cover its short-term obligations?
- Its current ratio is 14.05 — current assets exceed current liabilities.
- Where does AbCellera Biologics Inc.'s balance sheet data come from?
- Every line is extracted from AbCellera Biologics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
